Cardinal Partners

Cardinal Partners is a venture capital firm established in 1996, based in Princeton, New Jersey, with additional offices in Laguna Beach, California, and Wayne, Pennsylvania. The firm specializes in early-stage investments within the healthcare sector, focusing on healthcare information technology, medical technology, life sciences, medical products, and medical devices. Cardinal Partners primarily targets companies located in the United States, particularly in the Mid Atlantic region, and typically invests between $6 million and $12 million as a lead investor in the initial financing rounds of growth companies. Formerly known as Cardinal Health Partners, the firm is dedicated exclusively to healthcare investing.

John K. Clarke

Managing Partner

Thomas G. McKinley

General Partner

John J. Park

Partner and CFO

61 past transactions

aTyr Pharma

Series E in 2015
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.

Teladoc

Series A in 2009
Teladoc is a mission-driven organization, modernizing how people access and experience healthcare with a focus on high quality, lower costs, and improved outcomes around the world. The company’s award-winning, integrated clinical solutions are inclusive of telehealth, expert medical opinions, AI and analytics, and licensable platform services. With more than 2,000 employees, the organization delivers care in 125 countries and in more than 20 languages, partnering with employers, hospitals and health systems, and insurers to transform care delivery.

Medley Health

Series A in 2011
Medley Health is an innovative, entrepreneurial, technology-driven company. It's backed by top-tier investors and a management team with deep business expertise in healthcare, Internet and web services, as well as next-generation communications technologies.

Intellicare Group

Venture Round in 2022
Intellicare Group is engaged in the delivery of managed healthcare services via comprehensive, systematic, and prevention-oriented health maintenance programs or plans.

Cureatr

Venture Round in 2018
Cureatr is a comprehensive medication management (CMM) solutions company dedicated to repairing the United States’ $528 Billion, 275,000 deaths a year suboptimal medication management problem. We provide real-time, universal access to accurate medication data for over 265 Million patient and high-quality interventions by board certified telepharmacists. We have the expertise, resources, and technology to help you get the meds right and keep your patients out of the hospital.

IntelliCare

Series B in 2002
Providing 24-hour healthcare these days is a tough balancing act. Don't perform without a safety net you can trust. At IntelliCare, they know the ropes. They're a management company for medical call centers, and they work closely with health systems, provider networks and physician groups to make their operations a success. They offer experience, flexibility, commitment -- and a wide range of 24-hour telephonic and Web-based medical call center services that let you focus on what you do best. Making people feel better.

IC-USA

Series B in 2000
IC·USA is dedicated to improving outcomes for critical care patients.

Fluidnet

Series B in 2010
Fluidnet was founded in 2002 by a group of medical device professionals who collectively have over 100+ years of industry experience and product innovations. Based on the seacoast of scenic New Hampshire, Fluidnet is just north of Boston, providing access to a rich medical device community and first-rate research and development skills and facilities.

Sirtris Pharmaceuticals

Series A in 2004
[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)

aTyr Pharma

Series C in 2010
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.

Awarepoint

Venture Round in 2012
Awarepoint Corporation provides a cloud-based real-time locating system that delivers to track locations. The company offers analytical tools to transform real-time location data into operational intelligence; and managed services that include analysis, configuration, installation, validation, and training. It also provides a Temperature Monitoring System that enables medical facilities to maintain compliance to CDC Vaccines for Children program guidelines and ensure that vaccines are monitored within the recommended temperature range. The company serves clients in healthcare, manufacturing, retail, and other industries. Awarepoint Corporation was formerly known as NeverLost Networks, Inc. The company was founded in 2002 and is based in San Diego, California.

Roving Planet

Series C in 2005
Roving Planet, Inc. provides network access control and management solutions for enterprise networks. Its products provide a secure network environment by managing and controlling users, endpoints, connections, and sessions. The company serves enterprise, manufacturing, health, higher education, k-12, and aerospace government industries. Roving Planet, Inc. was founded in 2001 and is headquartered in Westminster, Colorado.

Ivenix

Venture Round in 2015
Ivenix is a medical technology company that develops a next-generation infusion management system. It is a venture-backed medical device company with a vision to transform infusion delivery in every care setting, globally. The company is focused on bringing its first product to market, a new and innovative infusion management system for hospitals. The system combines integrated state-of-the-art information technology and simplicity with an adaptive fluid delivery platform that continuously measures flow. The company was founded in 2007 and is headquartered in Amesbury, Massachusetts.

lifeIMAGE

Venture Round in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

lifeIMAGE

Series D in 2015
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Alnylam Pharmaceuticals

Venture Round in 2003
Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.

IntelliCare

Venture Round in 2000
Providing 24-hour healthcare these days is a tough balancing act. Don't perform without a safety net you can trust. At IntelliCare, they know the ropes. They're a management company for medical call centers, and they work closely with health systems, provider networks and physician groups to make their operations a success. They offer experience, flexibility, commitment -- and a wide range of 24-hour telephonic and Web-based medical call center services that let you focus on what you do best. Making people feel better.

Verastem

Series B in 2011
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Verastem

Series C in 2011
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Cureatr

Series A in 2013
Cureatr is a comprehensive medication management (CMM) solutions company dedicated to repairing the United States’ $528 Billion, 275,000 deaths a year suboptimal medication management problem. We provide real-time, universal access to accurate medication data for over 265 Million patient and high-quality interventions by board certified telepharmacists. We have the expertise, resources, and technology to help you get the meds right and keep your patients out of the hospital.

Awarepoint

Series D in 2008
Awarepoint Corporation provides a cloud-based real-time locating system that delivers to track locations. The company offers analytical tools to transform real-time location data into operational intelligence; and managed services that include analysis, configuration, installation, validation, and training. It also provides a Temperature Monitoring System that enables medical facilities to maintain compliance to CDC Vaccines for Children program guidelines and ensure that vaccines are monitored within the recommended temperature range. The company serves clients in healthcare, manufacturing, retail, and other industries. Awarepoint Corporation was formerly known as NeverLost Networks, Inc. The company was founded in 2002 and is based in San Diego, California.

QPID Health

Series A in 2013
QPID Health, Inc., a healthcare IT software company, delivers a health record intelligence platform and Web-based applications that enable healthcare institutions and clinicians to gain insights from electronic health records (EHRs). The company operates Queriable Programmable Inference Dossier (QPID), an intelligence system for the EHR that permits the creation of clinician-directed queries, analytics, and reporting abilities in real time and at the point of care. Its QPID platform aggregates EHR data, prepares information for search, and delivers meaningful information to clinicians and administrators in Web-based applications. QPID Health, Inc. is based in Boston, Massachusetts with locations in Boston, Massachusetts; and San Diego, California. As of February 26, 2016, QPID Health, Inc. operates as a subsidiary of eviCore healthcare.

CodeRyte

Series C in 2006
CodeRyte is the premier provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry. Their sophisticated technology streamlines the coding process and identifies clinically relevant information from medical records. Their clients secure their rightful reimbursement, enhance compliance and efficiency through computer-assisted coding. CodeRyte's data extraction solutions analyze the language of physician narratives and elevate previously undiscovered data for critical treatment and business decisions. Many of the nation's top physician practices, billing companies and academic medical centers rely on CodeRyte as the centerpiece of their coding and data mining operations.

Fluidnet

Series C in 2011
Fluidnet was founded in 2002 by a group of medical device professionals who collectively have over 100+ years of industry experience and product innovations. Based on the seacoast of scenic New Hampshire, Fluidnet is just north of Boston, providing access to a rich medical device community and first-rate research and development skills and facilities.

lifeIMAGE

Series C in 2013
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Teladoc

Venture Round in 2014
Teladoc is a mission-driven organization, modernizing how people access and experience healthcare with a focus on high quality, lower costs, and improved outcomes around the world. The company’s award-winning, integrated clinical solutions are inclusive of telehealth, expert medical opinions, AI and analytics, and licensable platform services. With more than 2,000 employees, the organization delivers care in 125 countries and in more than 20 languages, partnering with employers, hospitals and health systems, and insurers to transform care delivery.

Vascular Pharmaceuticals

Series A in 2012
Vascular Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutics for treating patients with type 1 and type 2 diabetes. It focuses on the development of VPI-2690B, a subcutaneously administered monoclonal antibody that is stimulated by hyperglycemia for the treatment of diabetic nephropathy. The company was founded in 2005 and is based in Research Triangle Park, North Carolina.

Verastem

Series A in 2010
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

NexCura

Series C in 2002
NexCura applications and custom services are made available through an application service provider (ASP) model on Web sites and are used to collect comprehensive clinical data and facilitate communication between patients and their physicians. The aggregate data They collect provides direct value to healthcare organizations, pharmaceutical companies, physicians, and patients.

Awarepoint

Series E in 2010
Awarepoint Corporation provides a cloud-based real-time locating system that delivers to track locations. The company offers analytical tools to transform real-time location data into operational intelligence; and managed services that include analysis, configuration, installation, validation, and training. It also provides a Temperature Monitoring System that enables medical facilities to maintain compliance to CDC Vaccines for Children program guidelines and ensure that vaccines are monitored within the recommended temperature range. The company serves clients in healthcare, manufacturing, retail, and other industries. Awarepoint Corporation was formerly known as NeverLost Networks, Inc. The company was founded in 2002 and is based in San Diego, California.

Momenta Pharmaceuticals

Series C in 2004
Biotechnology company specializing in the characterization and process engineering of complex molecules

Bioconnect Systems

Series A in 2007
Bioconnect Systems offers novel surgical implants and techniques that form precisely controlled vascular connections. The Optiflow family of sutureless anastomotic connectors provides a fast and repeatable method for connecting vessels. Bioconnect Systems was founded in 2006 and headquartered in Fort Washington, Pennsylvania.

Vitals

Series C in 2013
Sapphire Digital empowers everyone to shop for their health care like an expert. Their integrated high-tech, high-touch platform helps people select better, more affordable care. Sapphire Digital leads the market with incentive and engagement programs proven to drive new levels of activation. Their solutions achieve measurable and sustainable savings for consumers, employers and health plans. Over 280 million people each year rely on Vitals to help them decide on their care with confidence.

Privia Health

Private Equity Round in 2014
Privia Health, LLC operates as a physician practice management and population health technology company in the United States. The company offers physician group, care organization, and population health management programs working in partnership with health plans and national payers with reimbursement programs. Its cloud-based technology platform combines with an approach to patient engagement and physician-driven wellness focusing on building a better healthcare delivery system and patient population. Privia Health, LLC has strategic alliances with Premier Medical Group, P.C. and Children’s Health. The company was founded in 2007 and is based in Arlington, Virginia. Privia Health, LLC operates as a subsidiary of Brighton Health Services Holdings Corp.

Awarepoint

Series F in 2011
Awarepoint Corporation provides a cloud-based real-time locating system that delivers to track locations. The company offers analytical tools to transform real-time location data into operational intelligence; and managed services that include analysis, configuration, installation, validation, and training. It also provides a Temperature Monitoring System that enables medical facilities to maintain compliance to CDC Vaccines for Children program guidelines and ensure that vaccines are monitored within the recommended temperature range. The company serves clients in healthcare, manufacturing, retail, and other industries. Awarepoint Corporation was formerly known as NeverLost Networks, Inc. The company was founded in 2002 and is based in San Diego, California.

lifeIMAGE

Series B in 2011
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Awarepoint

Venture Round in 2010
Awarepoint Corporation provides a cloud-based real-time locating system that delivers to track locations. The company offers analytical tools to transform real-time location data into operational intelligence; and managed services that include analysis, configuration, installation, validation, and training. It also provides a Temperature Monitoring System that enables medical facilities to maintain compliance to CDC Vaccines for Children program guidelines and ensure that vaccines are monitored within the recommended temperature range. The company serves clients in healthcare, manufacturing, retail, and other industries. Awarepoint Corporation was formerly known as NeverLost Networks, Inc. The company was founded in 2002 and is based in San Diego, California.

AxoGen

Post in 2007
AxoGen, Inc. engages in the development of treatment options for the repair of peripheral nerve injuries. It offers AVANCE Nerve Graft, a human allograft nerve that is used for the repair, replacement, and reconstruction of damaged peripheral nerves. The company accepts orders through phone, fax, or email. It serves surgeons. AxoGen has a strategic tissue recovery partnership with American Tissue Services Foundation (ATSF). The company was founded in 2002 and is based in Alachua, Florida.

Momenta Pharmaceuticals

Series B in 2003
Biotechnology company specializing in the characterization and process engineering of complex molecules

Inspired Technologies

Series B in 2009
Inspired Technologies (North Huntingdon, PA) a commercial-stage medical device company focused on auto-titration of oxygen delivery for COPD patients.

Pointshare

Series C in 1999
Pointshare is a national leader in connecting local healthcare communities with secure, online business services that enhance communication, create efficiencies, and improve the delivery of care. Pointshare is the only company that has developed the technology, infrastructure, and hands-on service to create a proven, practical solution for automating the day-to-day business transactions of healthcare.

Cureatr

Series B in 2015
Cureatr is a comprehensive medication management (CMM) solutions company dedicated to repairing the United States’ $528 Billion, 275,000 deaths a year suboptimal medication management problem. We provide real-time, universal access to accurate medication data for over 265 Million patient and high-quality interventions by board certified telepharmacists. We have the expertise, resources, and technology to help you get the meds right and keep your patients out of the hospital.

CodeRyte

Series D in 2008
CodeRyte is the premier provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry. Their sophisticated technology streamlines the coding process and identifies clinically relevant information from medical records. Their clients secure their rightful reimbursement, enhance compliance and efficiency through computer-assisted coding. CodeRyte's data extraction solutions analyze the language of physician narratives and elevate previously undiscovered data for critical treatment and business decisions. Many of the nation's top physician practices, billing companies and academic medical centers rely on CodeRyte as the centerpiece of their coding and data mining operations.

lifeIMAGE

Series B in 2011
LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Teladoc

Series A in 2011
Teladoc is a mission-driven organization, modernizing how people access and experience healthcare with a focus on high quality, lower costs, and improved outcomes around the world. The company’s award-winning, integrated clinical solutions are inclusive of telehealth, expert medical opinions, AI and analytics, and licensable platform services. With more than 2,000 employees, the organization delivers care in 125 countries and in more than 20 languages, partnering with employers, hospitals and health systems, and insurers to transform care delivery.

Melinta

Series C in 2006
Melinta Therapeutics, Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes various anti-infectives for the treatment of bacterial infectious diseases in North America. It offers Baxdela, a monotherapy treatment of adult patients with acute bacterial skin or skin structure infections (ABSSSIs); Vabomere, an IV antibiotic used in treatment of gram-negative infections; Orbactiv, an IV antibiotic of the lipoglycopeptide class for the treatment of adult patients with ABSSSIs; and Minocin, a IV antibiotic of the tetracycline class with activity against gram-positive and gram-negative pathogens. The company has license agreements with Yale University, Medical Research Council, Wakunaga Pharmaceutical Co., Ltd., and CyDex Pharmaceuticals, Inc. Melinta Therapeutics, Inc. was founded in 2000 and is based in Morristown, New Jersey.

Teladoc

Series C in 2014
Teladoc is a mission-driven organization, modernizing how people access and experience healthcare with a focus on high quality, lower costs, and improved outcomes around the world. The company’s award-winning, integrated clinical solutions are inclusive of telehealth, expert medical opinions, AI and analytics, and licensable platform services. With more than 2,000 employees, the organization delivers care in 125 countries and in more than 20 languages, partnering with employers, hospitals and health systems, and insurers to transform care delivery.

Columbus Collaboratory, LLC

Private Placement in 2018
Columbus Collaboratory, LLC designs and develops intelligence exchange platform which supports real-time exchange of cybersecurity intelligence. The company also develops analytics-enhanced intelligence products. The company was incorporated in 2014 and is based in Columbus, Ohio.

aTyr Pharma

Series D in 2013
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.

Pointshare

Series B in 1999
Pointshare is a national leader in connecting local healthcare communities with secure, online business services that enhance communication, create efficiencies, and improve the delivery of care. Pointshare is the only company that has developed the technology, infrastructure, and hands-on service to create a proven, practical solution for automating the day-to-day business transactions of healthcare.

Inspired Technologies

Series A in 2007
Inspired Technologies (North Huntingdon, PA) a commercial-stage medical device company focused on auto-titration of oxygen delivery for COPD patients.

Sirtris Pharmaceuticals

Series B in 2005
[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)

aTyr Pharma

Series B in 2007
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.

aTyr Pharma

Series C in 2009
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.

Prealize Health

Series A in 2017
Prealize Health uses machine learning to transform healthcare from reactive to proactive so that more people can live healthier lives. The company identifies next year’s new high-cost members before a high-cost event occurs. And work with clinician teams to precisely target interventions that improve the quality of care and contain costs. Prealize empowers Health Plans, Employers, and Providers to see around the corner by predicting the what, why, and when of future risk. The company was founded in 2015 and based in Palo Alto, California.